The below disease modifying treatments (DMT’s) are available for the treatment of MS in New Zealand.
Tecfidera® (Dimethyl fumarate)
Copaxone® (glatiramer acetate)
Information on the entry and exit criteria for the PHARMAC funded treatments and application process.
Mavenclad® (Cladribine)
Stem cell therapy is any treatment that uses or targets stem cells